NXTC

Latest SEC Filings & News for NXTC

3 most recent filings and news items mentioning NXTC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/NXTC/news?limit=20"

Pull NXTC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Company commences review of strategic alternatives

NEXT-ChemX Corporation announced it has formed a special committee to evaluate potential strategic alternatives to enhance shareholder value. Market relevance is high, as this often signals a potential sale, merger, or major restructuring.

View filing at SEC.gov →

Dow Falls Over 100 Points Following Inflation Data; Crude Oil Gains

Dow Falls Over 100 Points Following Inflation Data; Crude Oil Gains

View filing at SEC.gov →

NextCure presents positive Phase 1 data for SIM0505 in gynecologic cancers

NextCure announced 55% objective response rate for SIM0505 in gynecologic cancers at ASCO 2026, with favorable safety in heavily pretreated patients. The data supports continued dose optimization and potential advancement toward pivotal trials for this CDH6-targeting antibody dru

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.